XML 119 R41.htm IDEA: XBRL DOCUMENT v3.23.2
Investments (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jul. 22, 2021
Apr. 01, 2021
Mar. 18, 2021
Mar. 15, 2021
Dec. 30, 2020
Dec. 19, 2020
Sep. 10, 2020
Sep. 30, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Sep. 30, 2021
Dec. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Marketable securities                 $ 148,000   $ 148,000          
Unrealized gain loss on investments                     (3,590,000)     $ (3,659,000)    
Investments                           $ 179,000    
Issuance of common stock, net of expenses                     268,000 $ 1,518,000        
Proceeds from Issuance of common stock                     1,518,000        
Vivacitas Agreement [Member]                                
Stock options exercised 1,000,000                              
Stock options exercised $ 1,000,000                              
Investment ownership percentage                           100.00%   100.00%
Investment Owned, Cost                           $ 4,100,000    
Common Stock [Member]                                
Issuance of common stock, net of expenses                     $ 25,000 $ 80,000        
Issuance of common stock, net of expenses, shares                     1,247,000 3,987,000        
BMI Capital International LLC [Member]                                
Issuance of common stock, net of expenses             $ 100,000                  
Investments equity method                 $ 22,000   $ 26,000          
Impact Oncology PTE Ltd. [Member]                                
Owners shares     2,480,000                          
Options to purchase additional shares     250,000                          
Consideration transferred     $ 2,480,000                          
Stemtech Corporation [Member] | Securities Purchase Agreement [Member]                                
Investments               $ 1,400,000         $ 1,400,000      
Consideration transferred                         1,400,000      
[custom:ConvertiblePromissoryNote-0]               $ 1,400,000         1,400,000      
[custom:OriginationFee]                         $ 500,000      
Debt Instrument, Maturity Date                         Sep. 09, 2024      
Debt Instrument, Interest Rate, Stated Percentage               10.00%         10.00%      
Stockholders' Equity, Other Shares                         154,173      
Class of Warrant or Right, Outstanding                           0 0  
Convertible Notes Payable                           $ 39,000 $ 44,000  
DSS Securities, Inc. [Member]                                
Equity method investment ownership percentage             14.90%                  
BMI Capital International LLC [Member]                                
Equity method investment ownership percentage             24.90%                  
BMI Capital International LLC [Member] | Minimum [Member]                                
Equity method investment ownership percentage             20.00%                  
Bio Med Technologies Asia Pacific Holdings Limited [Member]                                
Equity method investment ownership percentage           4.99%                    
Issuance of common stock, net of expenses           $ 632,000                    
Issuance of common stock, net of expenses, shares           525                    
Vivacitas Oncology Inc [Member] | Vivacitas Agreement [Member]                                
Equity method investment ownership percentage                           16.00%    
Moji Life LLC [Member] | Membership Unit Purchase Agreement [Member]                                
Equity method investment ownership percentage               30.75%         30.75%      
Payments to acquire equity method investments               $ 1,537,000                
Alset International Limited [Member]                                
Owners shares                 127,179,291   127,179,291     127,179,291    
Outstanding share percentage                           4.00%    
Marketable securities                 $ 1,501,000   $ 1,501,000     $ 3,319,000 $ 3,319,000  
Unrealized gain loss on investments                     1,945,000     1,068,000    
Alset International Limited [Member] | Executive Director And Chief Executive Officer [Member].                                
Unrealized gain loss on investments                 1,945,000 $ 1,068,000            
West Park Capital Inc [Member]                                
Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger         7.50%                      
Investments                 $ 500,000   $ 500,000     $ 500,000    
DSS Securities, Inc. [Member]                                
Issuance of common stock, net of expenses             $ 100,000                  
Outstanding membership interest             10.00%                  
Vivacitas Oncology Inc [Member]                                
Options to purchase additional shares       1,500,000                        
Shares issued, price per share       $ 1.00                        
Additional price per share       $ 1.00                        
Proceeds from Issuance of common stock       $ 500,000                        
Consideration transferred   $ 120,000                            
Sale of stock, description   the Company entered into an additional stock purchase agreement with Vivacitas (“Vivacitas Agreement #2”), whereas Vivacities wished to employ the service of the Chief Business Officer of Impact Biomedical, and in return for the services of this individual, Vivacitas shall issue to the Company, the aggregate purchase price for the Class A Common Shares of Vivacitas at the value of $1.00 per share shall be $120,000 to be paid in twelve (12) equal monthly installments for the period between April 1, 2021 and March 31, 2022.                            
Share Price   $ 1.00                            
Vivacitas Oncology Inc [Member] | Common Stock [Member]                                
Options to purchase additional shares       500,000